Jove
Visualize
联系我们

相关概念视频

Drug Discovery: Overview01:26

Drug Discovery: Overview

7.5K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

407
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
407
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

315
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
315
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
Bioequivalence: Overview01:16

Bioequivalence: Overview

921
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
921

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Systematic assessment of diverse RNA modifications using nanopore direct RNA sequencing.

Nucleic acids research·2026
Same author

Online Determination of mRNA Poly(A) Tail Length and Content.

Analytical chemistry·2025
Same author

Unified and Versatile Multiplex Platform for Expedited Method Development and Comprehensive Characterization of Therapeutic Peptides.

Analytical chemistry·2024
Same author

Analytical and Functional Characterization of Plasmid DNA Topological Forms and Multimers.

Analytical chemistry·2024
Same author

Online Nucleotide Mapping of mRNAs.

Analytical chemistry·2024
Same author

Separation of Plasmid DNA Topological Forms, Messenger RNA, and Lipid Nanoparticle Aggregates Using an Ultrawide Pore Size Exclusion Chromatography Column.

Analytical chemistry·2023
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Jun 4, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

赶上快速多样化的制药领域的发展.

Alexandre Goyon1

  • 1Synthetic Molecule Analytical Chemistry, Genentech, 1 DNA Way, South San Francisco, California 94080, United States.

ACS measurement science au
|December 23, 2024
PubMed
概括
此摘要是机器生成的。

新的治疗方式,如寡核酸,和基因疗法正在出现,呈现独特的分析挑战. 制定有效的策略对于表征这些复杂药物和确保其在开发过程中的质量至关重要.

更多相关视频

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.3K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.6K

相关实验视频

Last Updated: Jun 4, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.3K
High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
10:17

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

9.6K

科学领域:

  • 制药科学 制药科学
  • 分析化学 分析化学
  • 生物技术是生物技术.

背景情况:

  • 传统的小分子和抗体主导着制药.
  • 新兴的药物模式解决了"不可抗药"的目标,这是由生物学和化学的进步推动的.
  • 2023年,FDA对寡核酸,和基因疗法 (例如,CRISPR-Cas9) 获得了重大批准.

研究的目的:

  • 讨论新型药物模式所带来的分析表征挑战.
  • 分享洞察力和战略,以克服药物开发中的这些挑战.
  • 强调强大的分析方法对于新治疗方法的重要性.

主要方法:

  • 综述与各种药物模式 (寡核酸,,mRNA,DNA) 相关的分析挑战.
  • 讨论杂质分析,包括来自化学修饰的密切相关的杂质和二聚体 (例如酸酸盐).
  • 考虑mRNA和DNA的质量属性,例如polyA尾巴长度和限制效率.

主要成果:

  • 新型药物模式表现出多样化的物理化学性质,使分析表征复杂化.
  • 在合成和保质期期间的不洁物形成需要复杂的分离和分析技术.
  • 正角方法通常是必要的,以解决复杂的杂质配置文件,包括二聚体.

结论:

  • 由于新药模式的复杂性,对新药模式的分析表征需要量身定制的战略.
  • 在开发早期解决分析挑战对于数据驱动的决策至关重要.
  • 分析方法的持续创新对于支持新疗法不断发展的领域至关重要.